FDA 483 - Ex-Lax, Inc. - March 31, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Ex-Lax, Inc. in Humacao, PR, a manufacturer of pharmaceutical and animal drug products, revealed significant deficiencies in their manufacturing and quality control systems. Observations included inadequate process validation for animal drug products, incomplete batch records, and poorly documented investigations into quality events and deviations. Additionally, the firm failed to properly calibrate and maintain laboratory instruments and lacked sufficient detail in cleaning and maintenance procedures.
ID · 6f9b70f3-612b-43e5-95bb-6b3726c179ad